About Certara
What Certara is building
Technologies used at Certara
C++
AWS
SQLCompany culture
diversity
inclusion
Funding rounds
Total Funding
Last funding round type
Company type
Certara news and updates
Certara Inc. launched version of Biosimulation software on Jun 1st 22'.
In June 2022, Certara announced its new version of Biosimulation software for the progress of Novel Biologics.
Dec 19, 2022 | americantimesreporter.comCertara Inc. partnered with University of Cape Town on Mar 29th 22'.
Certara, Inc, a global leader in biosimulation, and Pharmacometrics Africa NPC, today announced a partnership with the University of Cape Town (UCT) to support its fellowship program for doctoral-level scientists from Africa.
Jan 1, 2022 | wcop2022.orgCertara Inc. received award 2022 Bronze Edison Award in the Therapeutic Impact category on May 3rd 22'.
Certara, Inc., a global leader in biosimulation, today announced that the Company’s Simcyp COVID-19 Vaccine Model has been awarded a 2022 Bronze Edison Award in the Therapeutic Impact category.
Jan 1, 2022 | biopharmadive.comCertara Inc. launched version 8.2 of Phoenix on Sep 1st 19'.
For instance, in September 2019, Certara Inc. launched version 8.2 of Phoenix, the most advanced and widely used validated software for PK, PD, and toxicokinetic modeling and simulation worldwide.
Jan 1, 2022 | jibonpata.comCertara Inc. launches versions of Immunogenicity, Immuno-oncology
Princeton, N.J., June 21, 2022: Certara, a global leader in biosimulation, today announced the release of new versions of its Immunogenicity (IG), Immuno-oncology (IO) and Vaccine Simulators to help predict how drugs work and address key questions in the development of novel biologic therapies.
Jan 1, 2022 | certara.comCertara Inc. hired Eran Broshy on Jul 11th 22'.
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Eran Broshy to its Board of Directors, effective July 11, 2022.
Jan 1, 2022 | certara.comCertara Inc. hired Rosemary Crane on Jul 21st 22'.
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Rosemary Crane to its Board of Directors, effective July 21, 2022.
Jan 1, 2022 | healthtechnologynet.comCertara Inc. partnered with MSK on Jul 28th 22'.
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a 2-year collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop new biosimulation software.
Jan 1, 2022 | cmocro.comEQT Group was planning to acquire Certara Inc. for $850M on Jul 18th 17'.
Private equity firm EQT is nearing a deal to acquire U.S. drug development consultancy Certara for around $850 million, including debt, from Arsenal Capital Partners, another buyout firm, people familiar with the matter said on Tuesday.
Jan 1, 2017 | nasdaq.comEQT Group acquired Certara Inc. on Jul 1st 17'.
July 2017: EQT Partners Inc. acquired Certara, which is a continuation of the convergence between healthcare and technology, as the industry further adopts biosimulation to advance drug development The report analyses how the stringent emission control norms will drive the global Biosimulation market.
Jan 1, 2017 | globalnewstribune.com